2Dellinger R P, Levy M M,Rhodes A, et al. Surviving Sepsis Cam- paign: International Guidelines forManagement of Severe Sepsisand Septic Shock, 2012[J]. Intensive Care Med, 2013, 39(2):165-228.
3Myburgh J A, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care[J]. N Engl J Med, 2012,367(20): 1901-1911.
4Perner A, Haase N, Guttormsen A B, et al. Hydroxyethyl starch 130/0.4 versus Ringer's acetate in severe sepsis[J]. N Engl J Med, 2012,367(2): 124-134.
5Rioux J P, Lessard M, De Bortoli B, et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery[J]. Critical care medicine, 2009,37(40):1293-1298.
6] Lissauer M E, Chi A, Kramer M E, et al. Association of 6% Het- astarch resuscitation with adverse outcomes in critically ill trauma patients[J]. Am J Surgery,2011,202(1):53-58.
7Schabinski F,Oishi J,Tuche F,et al. Effects of a predominantly hy- droxyethyl starch (HES)-based and a predominantly non HES- based fluid therapy on renal function in surgical ICU patients [J]. Intensive Care Medicine,2009, 35(9):1539-1547.
8Navickis R J, Haynes G R, Wilkes M M.Effect of hydroxyethyl starch on bleeding after cardio -pulmonary bypass: a meta-analysis of randomized trials [J]. J ThoracCardiovascSurg, 2012,144 (3): 223-230.
9FDA.Public Workshop-Risks and Benefits of Hydroxyethyl Starch Solutions[EB/OL]. (2012-09--06) [2014-05-04].http://www.fda.gov/ BiologicsBloodVaccines/NewsEvents/Workshops Meetings Conf- erences/ucm313370.html.
10EMA. PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or bum injuries or in critically ill patients[EB/OL]. (2013-10-11)[2014-05-04]http: //www.ema.europaeu/docs/en_GB/document_library/Press_release / 20 I3/IO/WC500151964.pdf.
